Back to Search
Start Over
Diffuse alveolar haemorrhage in children: an international multicentre study
- Source :
- Ring, A M, Schwerk, N, Kiper, N, Aslan, A T, Aurora, P, Ayats, R, Azevedo, I, Bandeira, T, Carlens, J, Castillo-Corullon, S, Cobanoglu, N, Elnazir, B, Emiralioğlu, N, Eyuboglu, T S, Fayon, M, Gursoy, T R, Hogg, C, Kötz, K, Karadag, B, Látalová, V, Krenke, K, Lange, J, Manali, E D, Osona, B, Papiris, S, Proesmann, M, Reix, P, Roditis, L, Rubak, S, Rumman, N, Snijders, D, Stehling, F, Weiss, L, Yalcın, E, Zirek, F, Bush, A, Clement, A, Griese, M, Buchvald, F F, Nathan, N & Nielsen, K G 2023, ' Diffuse alveolar haemorrhage in children : an international multicentre study ', ERJ Open Research, vol. 9, no. 2 . https://doi.org/10.1183/23120541.00733-2022
- Publication Year :
- 2023
-
Abstract
- BackgroundPaediatric diffuse alveolar haemorrhage (DAH) is a rare heterogeneous condition with limited knowledge on clinical presentation, treatment and outcome.MethodsA retrospective, descriptive multicentre follow-up study initiated from the European network for translational research in children's and adult interstitial lung disease (Cost Action CA16125) and chILD-EU CRC (the European Research Collaboration for Children's Interstitial Lung Disease). Inclusion criteria were DAH of any cause diagnosed before the age of 18 years.ResultsData of 124 patients from 26 centres (15 counties) were submitted, of whom 117 patients fulfilled the inclusion criteria. Diagnoses were idiopathic pulmonary haemosiderosis (n=35), DAH associated with autoimmune features (n=20), systemic and collagen disorders (n=18), immuno-allergic conditions (n=10), other childhood interstitial lung diseases (chILD) (n=5), autoinflammatory diseases (n=3), DAH secondary to other conditions (n=21) and nonspecified DAH (n=5). Median (IQR) age at onset was 5 (2.0–12.9) years. Most frequent clinical presentations were anaemia (87%), haemoptysis (42%), dyspnoea (35%) and cough (32%). Respiratory symptoms were absent in 23%. The most frequent medical treatment was systemic corticosteroids (93%), hydroxychloroquine (35%) and azathioprine (27%). Overall mortality was 13%. Long-term data demonstrated persistent abnormal radiology and a limited improvement in lung function.ConclusionsPaediatric DAH is highly heterogeneous regarding underlying causes and clinical presentation. The high mortality rate and number of patients with ongoing treatment years after onset of disease underline that DAH is a severe and often chronic condition. This large international study paves the way for further prospective clinical trials that will in the long term allow evidence-based treatment and follow-up recommendations to be determined.
- Subjects :
- Pulmonary and Respiratory Medicine
Internal Medicine Sciences
Klinik Tıp
RESPIRATORY SYSTEM
Medizin
Dahili Tıp Bilimleri
Göğüs Hastalıkları ve Allerji
CLINICAL MEDICINE
Sağlık Bilimleri
Clinical Medicine (MED)
Tıp
SOLUNUM SİSTEMİ
Health Sciences
Akciğer ve Solunum Tıbbı
Medicine
Klinik Tıp (MED)
Chest Diseases and Allergy
Subjects
Details
- Language :
- Turkish
- Database :
- OpenAIRE
- Journal :
- Ring, A M, Schwerk, N, Kiper, N, Aslan, A T, Aurora, P, Ayats, R, Azevedo, I, Bandeira, T, Carlens, J, Castillo-Corullon, S, Cobanoglu, N, Elnazir, B, Emiralioğlu, N, Eyuboglu, T S, Fayon, M, Gursoy, T R, Hogg, C, Kötz, K, Karadag, B, Látalová, V, Krenke, K, Lange, J, Manali, E D, Osona, B, Papiris, S, Proesmann, M, Reix, P, Roditis, L, Rubak, S, Rumman, N, Snijders, D, Stehling, F, Weiss, L, Yalcın, E, Zirek, F, Bush, A, Clement, A, Griese, M, Buchvald, F F, Nathan, N & Nielsen, K G 2023, ' Diffuse alveolar haemorrhage in children : an international multicentre study ', ERJ Open Research, vol. 9, no. 2 . https://doi.org/10.1183/23120541.00733-2022
- Accession number :
- edsair.doi.dedup.....50ea0892a565e020725a59d27e08bd40